Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, announced today it has successfully completed enrollment of its prospective, multicenter, post-CE Mark, international SAVE (Surfacer® System to Facilitate Access in VEnous Occlusions) Registry.
Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today welcomed the publication of the first reporting standards for thoracic central vein obstruction (TCVO) in the Journal of Vascular and Interventional Radiology (JVIR).
Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today announced the enrollment of its first patients in the SAVE-US (Surfacer® System to Facilitate Access in VEnous Occlusions – United States) pivotal trial.
Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today announced its upcoming Surfacer® Inside-Out® Access Catheter System educational events scheduled to take place at the Cardiovascular and Interventional Radiological Society of Europe(CIRSE) 2017 Annual Meeting in Copenhagen, Denmark.
Bluegrass Vascular Technologies, Inc. announced today that it has successfully enrolled over one third of its patients in the company’s post-market SAVE (Surfacer® System to Facilitate Access in VEnous Occlusions) Clinical Study. The SAVE study is an international, prospective, multicenter clinical follow-up study designed to confirm clinical performance and safety of the Surfacer® Inside-Out® Access Catheter System, a novel device indicated for obtaining central venous access to facilitate catheter insertion into the central venous system in patients with chronically occluded veins.
Bluegrass Vascular Technologies announced today that it is entering into a strategic relationship with Merit Medical Systems (Merit Medical), a leading manufacturer and marketer of proprietary disposable devices. The agreement will streamline European distribution of the recently CE mark approved Surfacer® Inside-Out® Access Catheter System and will provide funding to support the company’s efforts to secure FDA clearance for product sales in the U.S.
Publication: FierceBiotech Bluegrass Vascular nabbed a CE mark for its “inside-out” central venous catheter last summer. Now, the company is tapping Merit Medical to “streamline” the distribution of the device in Europe. “We are very pleased to be partnering with Merit Medical, a prominent distributor of medical devices in Europe and the U.S. that shares […]
Bluegrass Vascular Technologies today announced that it has received CE Mark approval and is launching limited commercial sale of its Surfacer® Inside-Out® Access Catheter System. The Surfacer System is indicated for obtaining central venous access to facilitate catheter insertion into the central venous system via a novel Inside-Out approach.
The Surfacer® Inside-Out Access® Catheter System procedure was performed under Germany’s “compassionate use” program,which grants access to physicians for use of medical devices not yet CE Mark approved in Europe, particularly in Germany, for patients who are diagnosed with advanced diseases and fail to respond to existing treatment options.
Bluegrass Vascular today announced the appointment of Dr. Gabriele Niederauer, a seasoned senior medical device executive, to President and CEO. Following the recent closure of Series A financing, BVT is focused on obtaining CE Mark for the Surfacer™ Inside-Out™ Access Catheter System, a proprietary system that allows physicians to gain venous access using a novel approach.